Skip to Content

Methocarbamol Pregnancy and Breastfeeding Warnings

Methocarbamol is also known as: Carbacot, Robaxin, Robaxin-750, Skelex

Medically reviewed on March 10, 2017

Methocarbamol Pregnancy Warnings

Methocarbamol has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Methocarbamol is not recommended for use in women who are or may become pregnant (particularly early pregnancy) unless in the judgment of the physician, the potential benefits outweigh the potential risks.

See references

Methocarbamol Breastfeeding Warnings

There are no data on the excretion of methocarbamol into human milk. Because many drugs are excreted into human milk, and because of the potential for serious adverse reactions in nursing infants from methocarbamol, nursing is not recommended for mothers on methocarbamol.

See references

References for pregnancy information

  1. "Product Information. Robaxin Injectable (methocarbamol)." Whitehall-Robbins, Madison, NJ.

References for breastfeeding information

  1. "Multum Information Services, Inc. Expert Review Panel"
  2. "Product Information. Robaxin Injectable (methocarbamol)." Whitehall-Robbins, Madison, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.